Search for: "SCHERING-PLOUGH"
Results 81 - 100
of 410
Sorted by Relevance
|
Sort by Date
30 Oct 2009, 3:11 pm
Schering-Plough Healthcare Products, Inc. v. [read post]
17 Aug 2011, 10:08 am
Schering-Plough Corp., No. [read post]
9 Feb 2009, 9:56 pm
Reddy's Resolve Patent Litigation Related to Claritin ® Patents On January 20, 2009, GeoPharma, based in Largo, FL, announced the settlement of its Clarinex ® (Desloratadine) ANDA patent litigation with Schering-Plough (based in Kenilworth, NJ) and Sepracor (based in Marlborough, MA) (see "Court Report," February 24, 2008). [read post]
22 Jul 2008, 3:05 pm
The Associated Press is reporting Schering-Plough and Merck's recent clinical trial fiasco involving their highly touted anti-cholesterol pill Vytorin, whereby a "European study in patients with heart valve disease found the drug didn't prevent worsening of the disease or lower the need for valve surgery. [read post]
6 Aug 2009, 8:40 am
And apparently, about 140 claimants could just imagine the execs at Merck and Schering-Plough humming along, as they buried (for about two years) an unfavorable study that showed the companies' jointly marketed cholesterol drugs, Vytorin and Zetia "were no more effective in unclogging arteries than a pre-existing and less expensive cholesterol treatment[s]. [read post]
1 Apr 2008, 11:03 pm
Vytorin, developed and marketed jointly by Merck and Schering-Plough, is a combination of cholesterol-lowering Zetia and the statin Zocor. [read post]
8 Jan 2008, 6:22 am
Drug makers Merck and Schering-Plough never published the results of studies regarding Zetia, an anti-hyperlipidemic drug often prescribed to lower cholesterol levels. [read post]
21 Jul 2014, 5:50 am
Articles Include: Meet RP’s Newest Superstar – Q&A with James Matthew Gould, former Schering-Plough and Merck In-House Counsel Practical Guidance for Defending Against Patent Trolls Protecting Trade Secrets at the ITC USPTO Addresses Meaning of “Real Party-In-Interest” for Inter Partes Review Read More [read post]
6 May 2009, 4:49 pm
Schering-Plough Corp. [read post]
20 Mar 2009, 2:20 am
The column returns to honor two lawyers behind two of the biggest, and most significant, transactions so far this year--Cooley Godward's Richard Climan advised Gilead Sciences on its $1.4 billion acquisition of CV Therapeutics, while Fried Frank's David Shine represented Merck in its $41 billion merger with Schering-Plough. [read post]
28 Apr 2010, 3:04 pm
I previously blogged the district court's rejection of a $690 million assignment of future income tax shelter in Schering-Plough v. [read post]
8 Dec 2008, 12:17 pm
Recent layoffs reported in the drug industry include Sanofi (650 sales reps);Novartis (550 U.S. salespersons);Merck (8,000); Wyeth (2,440); GSK (1,000); Schering-Plough (5,500);and Boehringer Ingelheim (200). [read post]
7 Jul 2011, 9:02 pm
, 132 Tax Notes 77 (July 5, 2011): Jackel reviews the recent Third Circuit Schering-Plough decision and attempts to determine whether the court’s express refusal to address the lower court’s economic substance analysis provides any guidance... [read post]
17 Aug 2011, 10:08 am
Schering-Plough Corp., No. [read post]
18 Dec 2008, 12:24 am
Lupin Ltd. has reported to settle all patent infringement lawsuits with Schering-Plough Corp. and Sepracor, Inc. relating anti-allergic drug Clarinex tablets, generically known as desloratadine. [read post]
12 Dec 2017, 11:33 am
The trial court denied Schering-Plough’s motion for a new trial.Schering-Plough appealed. [read post]
23 Dec 2008, 10:02 am
-based Schering-Plough and Marlborough, Mass. [read post]
29 May 2014, 1:40 pm
He has handled complex pharmaceutical and biotech patent cases throughout his career, most recently specializing in global patent litigation and IP licensing at Merck and Schering-Plough. [read post]
25 Mar 2009, 12:02 pm
NuvaRing® is manufactured by Organon and Akzo Nobel (now divisions of Schering Plough). [read post]
25 Mar 2008, 8:09 am
The staff of the Corporation Finance Division has allowed Schering-Plough and JP Morgan Chase to omit a new bylaw proposal that seeks an independent lead director after rejecting requests by AT&T and Boeing to exclude the same resolution. [read post]
